MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of investments
$93,972K
Net income (loss)
$37,890K
Sale of future
royalties, intellectual...
$43,935K
Disposals of property and
equipment
$42K
Loss on derivative
liability
-$7,216K
Income tax expense
$6,914K
Accounts and other
receivables
-$6,890K
Stock-based compensation
expense
$3,105K
Loss on
extinguishment of debt
-$2,756K
Prepaid expenses and
other current assets
-$2,053K
Discount and rebate
liabilities
$1,150K
Inventory write-down
$485K
something is missing
$476K
Other liabilities
$416K
Depreciation and
amortization expense
$368K
Non-cash interest
expense
$341K
Fair value
adjustment related to...
$216K
Non-cash lease expense
$118K
Net cash provided by
investing activities
$79,618K
Net cash provided by
(used in) operating...
$6,142K
Effect of exchange rate
changes on cash and cash...
$233K
Canceled cashflow
$58,331K
Canceled cashflow
$64,252K
Net increase in cash
and cash...
$33,189K
Canceled cashflow
$52,804K
Purchases of investments
$58,296K
Purchases of property and
equipment
$35K
Proceeds from issuance of
common stock for...
$9,171K
something is missing
$3,520K
Gain on sale of future
royalties, intellectual...
$43,314K
Cash paid to settle
derivative instrument and...
$9,016K
Settlement of royalties to
aquestive
-$4,393K
Paid-in-kind interest
$3,134K
(gain) loss on foreign
currency exchange rates
$1,403K
Fair value
adjustment related to...
-$968K
Accretion on investments
$624K
Accounts payable and
accrued expenses
-$529K
Operating lease
right-of-use assets
$476K
Inventories
$185K
Operating lease
liabilities
-$123K
Other long-term
assets
$87K
Net cash (used in)
provided by financing...
-$52,804K
Canceled cashflow
$12,691K
Repayment of debt
$60,092K
Proceeds from issuance of
common stock for...
-$2,768K
Payments for employee
taxes related to stock...
$2,635K
Back
Back
Cash Flow
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)
source: myfinsight.com